Jane Street
RLAY icon

Jane Street’s Relay Therapeutics RLAY Stock Holding History

Jane Street’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$146K Buy
+14,700
New +$132K ﹤0.01% 10409
2022
Q2 		– Sell
-15,900
Closed -$476K – 10682
2022
Q1 		$476K Buy
+15,900
New +$386K ﹤0.01% 7585
2021
Q4 		– Sell
-6,500
Closed -$205K – 10706
2021
Q3 		$205K Buy
+6,500
New +$219K ﹤0.01% 8803

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Jane Street's RLAY Position: Q1 2026 in Review

Jane Street increased its Relay Therapeutics (RLAY) stake by 454% in Q1 2026, buying an estimated $3.1M and bringing the position to 423,536 shares worth $4.21M. The position accounts for ﹤0.01% of the portfolio, ranked #3755.

Jane Street first reported a position in RLAY in Q1 2021 and has held it in 17 quarters since. 242 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Jane Street held 423,536 shares of Relay Therapeutics worth $4.21M as of Q1 2026.
  • Jane Street bought 347,060 Relay Therapeutics shares in Q1 2026, an estimated $3.1M.
  • Relay Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3755 holding.
  • Jane Street first reported a position in Relay Therapeutics in Q1 2021 and has held it in 17 quarters since.
  • 242 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.